Podcasts about Mobi

Mobile attribution is getting better than ever before. And that's in spite of it becoming more and more complex.There's so many measurement methodologies. Advanced SAN. AEM. Advanced AEM. Unified Measurement. SKAN. AAK. Privacy Sandbox. GAID. IDFA. Probabilistic. Modeled.You name it, there's MORE of everything.But in spite of all that, mobile attribution is getting better. Way better. And maybe, it's actually BECAUSE of all that. And the great news: it's also getting EASIER.Makes sense? Insane?Impossible?Check out this convo in Growth Masterminds between John Koetsier and Singular CTO Eran Friedman

This is the seventh chapter “Supreme Peace: Nibbāna” from the book: Buddhadhamma: The Laws Of Nature And Their Benefits To Life by Bhikkhu P. A. Payutto (Somdet Phra Buddhaghosacariya) Published by Buddhadhamma FoundationCopyright © Buddhadhamma Foundation 2021Translated by Robin Philip Moore Editor: Bhikkhu Kovilo, typesetting: Bhikkhu Gambhīro Download this e-book in PDF, EPUB and MOBI formats atContinue reading "“Awakened Beings” Chapter 7 From Buddhadhamma: The Laws Of Nature And Their Benefits To Life"

Video Version Only on HCPLive! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, reflect on major announcements and product updates from the Advanced Technologies & Treatments for Diabetes (ATTD) 2025 annual conference. The conversation opens with insights into Medtronic's new Simplera CGM, emphasizing its single-use, disposable design and fully disposable on-body form factor. The hosts highlight improvements over previous iterations, such as the absence of an inserter and a more streamlined adhesive system. Although accuracy data have yet to be released, Medtronic has initiated a pivotal trial, and expectations are high for competitive MARD performance. They then turn to Tandem Diabetes Care's Tandem Mobi pump, recently launched in the US market. The pump's compact size and phone control interface are praised for improving convenience and discretion. Bellini underscores how Mobi shifts the paradigm for pump wearability, with early feedback from patients indicating high satisfaction. Later, the hosts discuss Beta Bionics' insulin-only iLet Bionic Pancreas system, which has expanded availability in the U.S. They review recent clinical updates and ongoing efforts to integrate real-world user data. The system's unique algorithm, which doesn't require manual carb counting or standard pre-programming, continues to generate interest across clinical settings. Additional topics include anticipated innovation from Lilly's new pump platform, the competitive implications for CGM integration, and an emphasis on patient-centered device design. The episode closes with Isaacs and Bellini reflecting on the rapid evolution of diabetes technology and how practitioners can stay current with emerging tools and evidence-based practices. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others. Editor's Note: Control-IQ+ technology is cleared by the FDA for use in adults with type 2 diabetes in the United States, as of February 25, 2025. The podcast episode erroneously positioned the indication as forthcoming. On March 18, 2025, Tandem Diabetes Care announced the commercial launch, making Control-IQ+ available for people with type 1 diabetes ages 2 years and older and adults with type 2 diabetes.

“Ease of use is what drives adoption,” Tandem Diabetes CEO John Sheridan explains to Bloomberg Intelligence about what can fuel further insulin-pump penetration. In this episode of Vanguards of Health Care, Sheridan sits down with BI analyst Matt Henriksson for an in-depth interview about Tandem’s Mobi pump, designed for discretion and simplicity, and the AI-powered Control-IQ Plus algorithm, now approved for both type 1 and type 2 diabetes. The conversation also touches on the company’s international market strategy, value-based reimbursement and future product development, including the tubeless Sigi.See omnystudio.com/listener for privacy information.

W najnowszym odcinku Podcastów IZ analitycy ds. niemieckiej polityki zagranicznej i bezpieczeństwa, dr Karol Janoś i prof. Krzysztof Malinowski rozmawiają z dr Bogumiłem Rudawskim o bestsellerowej książce Sönkego Neitzela „Niemieccy wojownicy. Historia militarna Niemiec od Cesarstwa do Republiki Berlińskiej”, której polskie wydanie właśnie ukazało się nakładem Wydawnictwa Instytutu Zachodniego. Link do zakupu książki: https://www.iz.poznan.pl/ksiegarnia/pl/strona-glowna/245-niemieccy-wojownicy-historia-militarna-niemiec-od-cesarstwa-do-republiki-berlinskiej.html Wersja elektroniczna: PDF, EPUB, MOBI: https://www.iz.poznan.pl/ksiegarnia/pl/strona-glowna/246-niemieccy-wojownicy-historia-militarna-niemiec-od-cesarstwa-do-republiki-berlinskiej-pdf-epub-mobi.html

Just Rambo this week. - New Song- Latest patch notes- Cloud vs Cam accounts- EE has an appstore advert being promoted by apple.- SHH loses Citadel in ER, SUS dropped on them.- PHPC joins SHH, - Kobra and SpacePope should be corpies- NE qq account has RMT sales - Mobi Mountain- Things I may have missed/comments

Émission du 21/03/2025 Représenter l'État ou être élue locale Troisième émission de cette série d'émissions « Explosons le plafond » mise en place avec Geoffrey, en service civique avec Mobiüs-Band, à l'occasion du mois des droits des femmes, à retrouver également sur le créneau de Sortez ! Problème de parité, difficulté d'accès aux postes à responsabilités, retour […] L'article La Méridienne x Möbius-Band : Explosons le plafond#3 est apparu en premier sur Radio Campus Tours - 99.5 FM.

Émission du 21/03/2025 Femmes à l’université et entreprenariat au féminin Quatrième et dernière émission de cette série d'émissions « Explosons le plafond » mise en place avec Geoffrey, en service civique avec Mobiüs-Band, à l'occasion du mois des droits des femmes, à retrouver également sur le créneau de La Méridienne ! Problème de parité, difficulté d'accès aux […] L'article Sortez ! x Mobiüs-Band : Explosons le plafond#4 est apparu en premier sur Radio Campus Tours - 99.5 FM.

Émission du 20/03/2025 Femmes dirigeantes de structures culturelles Seconde émission de cette série d’émissions « Explosons le plafond » mise en place avec Geoffrey, en service civique avec Mobiüs-Band, à l'occasion du mois des droits des femmes, à retrouver également sur le créneau de Sortez ! Problème de parité, difficulté d'accès aux postes à responsabilités, retour sur […] L'article La Méridienne x Mobiüs-Band : Explosons le plafond#2 est apparu en premier sur Radio Campus Tours - 99.5 FM.

Émission du 18/03/2025 Femmes dans les structures culturelles et d’innovation Première émission de cette série « Explosons le plafond » mise en place avec Geoffrey, en service civique avec Mobiüs-Band à l’occasion du mois des droits des femmes, à retrouver également sur le créneau de la Méridienne ! Et on commence fort avec Catherine Lenoble, directrice de […] L'article Sortez ! x Mobiüs-Band : Explosons le plafond#1 est apparu en premier sur Radio Campus Tours - 99.5 FM.

This is the sixth chapter “Supreme Peace: Nibbāna” from the book: Buddhadhamma: The Laws Of Nature And Their Benefits To Life by Bhikkhu P. A. Payutto (Somdet Phra Buddhaghosacariya) Published by Buddhadhamma FoundationCopyright © Buddhadhamma Foundation 2021Translated by Robin Philip Moore Editor: Bhikkhu Kovilo, typesetting: Bhikkhu Gambhīro Download this e-book in PDF, EPUB and MOBI formats atContinue reading "“Supreme Peace: Nibbāna” Chapter 6 From Buddhadhamma: The Laws Of Nature And Their Benefits To Life"

The Oregon Coast: 363 Miles of Possibilities and Experiences on The People's CoastIn this Outdoor Adventure Series podcast episode, we're thrilled to welcome Lynnee Jacks, the Industry Communications Coordinator for the Oregon Coast Visitors Association. Lynnee is passionate about sharing the natural beauty and diverse recreational opportunities found along the 363 miles of the Oregon coastline. Join us as we delve into the history, culture, and environmental stewardship that make the Oregon coast a cherished destination for visitors and locals alike and will inspire you to visit the People's Coast.DISCUSSION POINTSLynnee describes the Oregon Coast's diversity and beauty and her personal connection to the region.The ways has the Oregon Coast Visitors Association evolved over the years to address the changing needs and desires of tourists and locals.The "traditional" versus "non-traditional" adventures available on the Oregon Coast and how the region is diversifying its recreational opportunitiesThe key strategies the Oregon Coast Visitors Association uses to manage tourism impacts and ensure sustainable visitation.The ways the Oregon Coast region is working to make its beaches and trails more accessible to people with disabilities, as mentioned in the conversation.The ways Oregon Coast Visitors Association incorporate relaxation and wellness into their tourism offerings, and why is this important.The significance of the Oregon Coast's fishing industry and how the association aims to keep more local seafood in the region.The ways the Oregon Coast Visitors Association engages visitors in conservation and stewardship activities and the impact it has on local communities and ecosystems.Lynnee's "Aha Moment" related to the introduction of Moby Mats and why initiatives like this are important for locals and tourists on the coast.CONNECT WITH THE OREGON COASTTo see everything the Peoples Coast has to offer, visit the Oregon Coast website at https://visittheoregoncoast.com/ and follow their social media channels for the latest updates and travel inspiration:Facebook: https://www.facebook.com/ThePeoplesCoastInstagram: https://instagram.com/thepeoplescoastYouTube: https://www.youtube.com/channel/UCpqhcUNwZ9aBH-g6BcGLYOgNEXT STEPSVisit us at https://outdooradventureseries.com. We welcome likes, comments, and shares.KEYWORDSLynnee Jacks, The Peoples Coast, The Oregon Coast, Pacific Northwest Sustainability, Accessibility, Mobi-mat, Mental Health, Outdoor Adventure Series, Podcast#ThePeoplesCoast #TheOregonCoast #PNW #Tourism #Sustainability #Accessibility #MobiMat #MentalHealth #OutdoorAdventures #Podcast My Favorite Podcast Tools: Production by Descript Hosting Buzzsprout Show Notes by Castmagic Website powered by Podpage Be a Podcast Guest by PodMatch

Rambo, Jubi, and OC cant stop have a pre super bowl podcast where they talk about the game update, what it broke, all the rorq losses that happened, as well as some other things. Mobi mountain segment had some additional slides, and they give away a duo omega for the pvp ship winner of the week. 

Did you know how artificial intelligence is shaping the future of the hospitality industry?  In this episode of The Modern Hotelier, we sit down with Harriet Brown, VP of Product at Mobi.AI, to explore how artificial intelligence is revolutionizing the hospitality industry. Harriet shares insights from her impressive career, spanning AI, machine learning, and travel technology, including her time at Google and ITA Software.From personalization challenges to the future of AI in hospitality, Harriet offers a thought-provoking perspective on what's next for the industry. Plus, hear her advice for businesses hesitant to adopt AI and her favourite "aha" moments while building at Mobi. AI.Key Topics: How Mobi AI enhances decision-making and productivity for travelers and travel agents The importance of emotional loyalty in travel, alongside transactional loyalty What are Harriet's insights on adapting AI tools effectively and avoiding analysis paralysis Tips for creating loyalty through technology-enhanced experiences.If you're passionate about hospitality, tech innovation, or travel, this is an episode you don't want to miss!

No youtube stream on this episode.- Game News- Space Pope interaction- EE Spelling Bee, Asheeved vs Jubi- Mobi mountain week 4

00:00:00 - Intro 00:10:00 - patch notes 00:49:00 - AOS SoV Bill 00:54:00 - DDR Interview 01:20:00 - Weekend Update 01:28:00 - Community News 01:38:00 - AMA 02:02:00 - mobi mountain

Artificial Intelligence expert and founder of Bastyon, Daniel Satchkov, rejoins the program to discuss what AI is and what it is not. How they are likely propagandizing the public to believe AI is more than it it. We also discuss how those jobs that are akin to being part of an algorithm can be automated. This means most elite jobs such as MDs, marketing, and finance can be automated while the trades, nurses and other jobs are much harder to automate.You can learn more about Daniel Satchkov at https://bastyon.com/Daniel_Satchkov.Buy or learn more about the MOBI phone at https://bastyon.mobi/en/sarahwestall/

S6:E2 00:00:00 Intros (ad lib per hosts) 00:06:00 Game News (Official game announcements off Discord, Patch notes, leaked content) Leaked event stuff 00:33:00 Community News, Jubi joins another corp, Corp Tech stuff 00:37:40 Dark Aurora situation 01:10:00 Joda/Pand drama 01:17:00 Corp Tech 01:20:00 First Fortizar KM 01:24:00 New Kraken exec, SmoothMinimal, along with Sarp. 01:28:00 MOBI Mountain - Weekly PVP ranking

Stephanie uses a Mobi pump and has had type 1 for 26 years. Get Gvoke HypoPen CONTOUR NextGen smart meter and CONTOUR DIABETES app Learn about the Dexcom G6 and G7 CGM Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 JUICE CRUISE 2025 Screen It Like You Mean It Eversense CGM Learn about the Medtronic Champions This BetterHelp link saves 10% on your first month of therapy Try delicious AG1 - Drink AG1.com/Juicebox I Have Vision Use code JUICEBOX to save 40% at Cozy Earth  Learn about Touched By Type 1 Take the T1DExchange survey *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on Apple Podcasts. Thank you! The Juicebox Podcast is not a charitable organization.  

An airhacks.fm conversation with Phillip Krueger (@phillipkruger) about: early programming experiences with Visual Basic and Java, transition from actuarial science to computer science, first job at a bank working with Java Swing and RMI over CORBA, experience with J2EE and XML technologies, working with XML and XSLT, development of open-source Swing components, work on dotMobi sites for mobile phones in Africa, creation of API extensions for Java EE and MicroProfile, involvement in the MicroProfile GraphQL specification, joining Red Hat and working on quarkus, development of SmallRye GraphQL, improvements to OpenAPI support in Quarkus, work on Quarkus Dev UI, discussion about the evolution of Java application servers and frameworks, comparison of REST and GraphQL, thoughts on Java development culture in South Africa Phillip Krueger on twitter: @phillipkruger

Join me as I chat with Dr. Laurel Messer, Tandem's Senior Director of Medical Affairs, who brings 20+ years of experience in diabetes care, education, and research. 75% of clients coming to Risely are already using automated insulin delivery systems, which shows us that technology doesn't necessarily solve all of our problems living with T1D, right? Today's conversation with Dr. Messer offers insights on why users love Mobi, how to overcome barriers of use to Control IQ technology, what critical mindset shift is needed with automated insulin delivery, plus how to optimize technology and break old, unhelpful habits. With a deep understanding of patient care and technology, Dr. Messer offers a glimpse into the future of diabetes innovation that you can start being a part of now!Time Stamps:  (03:58) “I was a nurse first - nurses bear witness to the human experience”(06:25) What Surprised Her the Most About People Living with Diabetes (08:26) Her Role at Tandem (09:47) Control IQ Technology (11:20) User Feedback on Mobi Wearability, Ease of Use, and Control IQ(15:54) Tandem's Development of Mobi and Overcoming Barriers to Using Tech(17:51) Shifting Mindsets on Automated Insulin Delivery(21:50) Optimizing the Technology and Knowing Your Body's Patterns(26:08) How Old Habits Block Tech Optimization(31:09) Who is a Good Candidate for Automated Insulin Delivery Systems?(35:05) Where is Tandem and Technology Going?What to do now:Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop when new episodes drop.Doors are open for the January 2025 round of our signature group coaching program. Apply for coaching and talk to our team so you can reclaim the life you deserve. Check out the world's smallest, durable automated insulin delivery system, the Tandem Mobi HERE.Disclaimer: Nothing you hear on the Reclaim your Rise podcast should be a substitute for personalized professional medical advice. Please always consult your physician or other medical professional before making any changes to your diet, insulin dosages, or healthcare plan. 

Send us a textDiscover how Maxx turned setbacks into stepping stones, overcoming supply chain woes and financial turmoil, only to emerge with Madison Braids—a brand that skyrocketed to a $3 million triumph. Imagine having the insights to double, even triple your ROI with laser-focused strategies; this episode holds the keys to that paradigm shift.In this episode, Jordan West with Maxx Blank, a cofounder of Triple Whale, as he shares the incredible evolution of his ecommerce ventures. Our conversation navigates through Maxx's early days launching boutique operations like Ivy and Fig, to his current success with Triple Whale, a game-changing analytics platform for Shopify merchants. Join us as we explore Maxx's lessons learned from navigating supply chain challenges, leveraging Facebook ads, and developing cutting-edge solutions for the future of social commerce.Listen and learn in this episode!Key takeaways from this episode:Ecommerce Opportunities and Challenges: The initial phase (2015-2016) offered great opportunities in ecommerce via platforms like Facebook, but also brought challenges with supply chain and marketing.Targeting Niche Markets: Madison Braids' success shows the value of focusing on niche markets and how expanding to broader audiences can drive scalability.Robust Data Platforms: Triple Whale's evolution from a dashboard to a comprehensive data platform highlights the importance of meeting real business needs, especially in ad attribution and real-time analytics.Leveraging AI for Insights: The development of "Mobi" showcases the benefits of using AI tools to generate data insights and automate workflows, aiding effective business decisions.Adaptability: Maxx emphasizes staying flexible and skeptical of absolute predictions, which is crucial for navigating business changes and consumer shifts.Community Engagement: Events like the Whalies play a key role in building brand loyalty and recognition within the industry through community engagement.Pandemic-Induced Shifts: The ecommerce boom during COVID spotlighted the necessity for businesses to adapt strategies in response to external shifts.User-Driven Growth: Triple Whale's growth illustrates the power of user engagement in product development, leading to organic expansion.Today's Guest: Maxx Blank, cofounder of Triple Whale. Maxx is highly connected to the ecommerce industry, particularly in data analytics and marketing strategy. He is an expert in developing platforms that provide comprehensive analytics solutions for ecommerce businesses, addressing challenges like ad attribution, and evolving products to support multi-touch attribution and real-time data visualizations.Growth Plan: www.upgrowthcommerce.com/growMillion Dollar Offers: www.upgrowthcommerce.com/growIn this episode's sponsor is Revenued - is a financial technology company that provides businesses with revenue-based financing solutions. Instead of relying on credit scores or collateral, Revenued offers funding based on a company's revenue. This allows businesses to access capital quickly and repay it as they generate income. Learn more here: Revenued

This is the fourth chapter “Dependent Origination” in/from the book: Buddhadhamma: The Laws of Nature and Their Benefits to Lifeby Bhikkhu P. A. Payutto (Somdet Phra Buddhaghosacariya) Published by Buddhadhamma FoundationCopyright © Buddhadhamma Foundation 2021Translated by Robin Philip Moore Editor: Bhikkhu Kovilo, typesetting: Bhikkhu Gambhīro Download this e-book in PDF, EPUB and MOBI formats at the followingContinue reading "“Dependent Origination” Chapter 4 From Buddhadhamma: The Laws Of Nature And Their Benefits To Life"

White hat researchers managed to take over WHOIS for the .mobi TLD. Among other things, this discovery foretells the death of WHOIS as a valid email source for Domain Control Validation (DCV).

This week, we discuss IBM acquiring Kubecost, AWS moving OpenSearch to the Linux Foundation, and Amazon employees heading back to the office. Plus, some thoughts on what it means to be in "employee mode." Watch the YouTube Live Recording of Episode (https://www.youtube.com/watch?v=aWj5n7LWCdk) 485 (https://www.youtube.com/watch?v=aWj5n7LWCdk) Runner-up Titles That's a good looking setup there Feels like sweatpants London's busy, Amsterdam's laid back AIFinOps Mission Bankruptcy The settings page is more than 1 page Don't get turned into hamburger, that's the goal Feature checkbox acquisition. Employee Mode Using people as a whiteboard. Work on smarter things, not dumber things. Rundown Announcing Kubecost's Acquisition by IBM! (https://blog.kubecost.com/blog/ibm-acquisition-announcement/) AWS hands OpenSearch to the Linux Foundation (https://www.infoworld.com/article/3520875/aws-hands-opensearch-to-the-linux-foundation.html?utm_medium=social&utm_content=content&utm_campaign=organic&utm_source=twitter) Update from Amazon CEO Andy Jassy on return-to-office plans and manager team ratio (https://www.aboutamazon.com/news/company-news/ceo-andy-jassy-latest-update-on-amazon-return-to-office-manager-team-ratio) JPMorgan creates new role overseeing junior bankers as Wall Street wrestles with workload concerns (https://www.cnbc.com/2024/09/18/jpmorgan-investment-bank-creates-new-role-overseeing-junior-bankers.html) Relevant to your Interests OpenAI Fundraising Set to Vault Startup's Value to $150 Billion (https://www.bloomberg.com/news/articles/2024-09-11/openai-fundraising-set-to-vault-startup-s-value-to-150-billion) Lyft CEO keeps it real on his stock price compared to Uber (https://finance.yahoo.com/news/lyft-ceo-keeps-it-real-on-his-stock-price-compared-to-uber-230146967.html) We Spent $20 To Achieve RCE And Accidentally Became The Admins Of .MOBI (https://labs.watchtowr.com/we-spent-20-to-achieve-rce-and-accidentally-became-the-admins-of-mobi/) How China has ‘throttled' its private sector (https://www.ft.com/content/1e9e7544-974c-4662-a901-d30c4ab56eb7) Wall Street Curbs Young Bankers' Hours After Overwork Outcry (https://www.wsj.com/finance/banking/bank-america-jpmorgan-overtime-work-hours-f9f204a7) Unity is Canceling the Runtime Fee (https://unity.com/blog/unity-is-canceling-the-runtime-fee) Intel Awarded up to $3B by the Biden-Harris Administration (https://www.intel.com/content/www/us/en/newsroom/news/2024-intel-news.html) Free 'JavaScript' from Legal Clutches of Oracle, Devs Petition (https://thenewstack.io/free-javascript-from-legal-clutches-of-oracle-devs-petition/) Instagram makes teen accounts private by default (https://www.platformer.news/instagram-teen-accounts-private-default-daily-limit/?ref=platformer-newsletter) Cisco's second layoff of 2024 affects thousands of employees (https://techcrunch.com/2024/09/17/ciscos-second-layoff-of-2024-affect-thousands-of-employees/) Call For Proposals (CFP) | LF Events (https://events.linuxfoundation.org/kubecon-cloudnativecon-europe/program/cfp/) Londoners will soon see drones ferrying blood between hospitals (https://techcrunch.com/2024/09/17/londoners-will-soon-see-drones-ferrying-blood-between-hospitals/) Nonsense Polishing Cloth (https://www.apple.com/shop/product/MW693AM/A/polishing-cloth) United Airlines is adding free Starlink Wi-Fi to all of its planes (https://www.theverge.com/2024/9/13/24243594/united-airlines-free-starlink-wi-fi-connectivity) Founder mode, baby #tech #founder #foundermode (https://www.tiktok.com/t/ZTFFRvSv1/) Chipotle's New Guac Robots Can Peel Your Avocados in 26 Seconds (https://www.bloomberg.com/news/articles/2024-09-16/chipotle-cmg-robots-for-guac-and-bowls-are-ready-for-brisket-season) LinkedIn Roaster - Brutal honesty for your profile (https://liroast.web.app/) SpaceX Starlink has 2,500 airplanes under contract after United megadeal, director says (https://www.cnbc.com/2024/09/17/spacexs-starlink-has-2500-aircraft-under-contract.html) Passport renewals go digital to ease wait times for American travelers (https://www.axios.com/2024/09/18/online-passport-renewal-us-travelers?utm_campaign=editorial&utm_medium=social&utm_source=twitter) Conferences Cloud Foundry Day EU (https://events.linuxfoundation.org/cloud-foundry-day-europe/), Karlsruhe, GER, Oct 9, 2024, 20% off with code CFEU24VMW. VMware Explore Barcelona (https://www.vmware.com/explore/eu), Nov 4-7, 2024. Coté speaking. SREday Amsterdam (https://sreday.com/2024-amsterdam/), Nov 21, 2024. Coté speaking (https://sreday.com/2024-amsterdam/Michael_Cote_VMwarePivotal_We_Fear_Change), 20% off with code SRE20DAY. DevOpsDayLA (https://www.socallinuxexpo.org/scale/22x/events/devopsday-la) at SCALE22x (https://www.socallinuxexpo.org/scale/22x), March 6-9, 2025, discount code DEVOP SDT News & Community Join our Slack community (https://softwaredefinedtalk.slack.com/join/shared_invite/zt-1hn55iv5d-UTfN7mVX1D9D5ExRt3ZJYQ#/shared-invite/email) Email the show: questions@softwaredefinedtalk.com (mailto:questions@softwaredefinedtalk.com) Free stickers: Email your address to stickers@softwaredefinedtalk.com (mailto:stickers@softwaredefinedtalk.com) Follow us on social media: Twitter (https://twitter.com/softwaredeftalk), Threads (https://www.threads.net/@softwaredefinedtalk), Mastodon (https://hachyderm.io/@softwaredefinedtalk), LinkedIn (https://www.linkedin.com/company/software-defined-talk/), BlueSky (https://bsky.app/profile/softwaredefinedtalk.com) Watch us on: Twitch (https://www.twitch.tv/sdtpodcast), YouTube (https://www.youtube.com/channel/UCi3OJPV6h9tp-hbsGBLGsDQ/featured), Instagram (https://www.instagram.com/softwaredefinedtalk/), TikTok (https://www.tiktok.com/@softwaredefinedtalk) Book offer: Use code SDT for $20 off "Digital WTF" by Coté (https://leanpub.com/digitalwtf/c/sdt) Sponsor the show (https://www.softwaredefinedtalk.com/ads): ads@softwaredefinedtalk.com (mailto:ads@softwaredefinedtalk.com) Recommendations Brandon: iPhone Mirroring: Use your iPhone from your Mac (https://support.apple.com/en-us/120421) Matt: NSW Electoral Commission (https://vtr.elections.nsw.gov.au/LG2401) Coté: Code to Production: From Cloud to DevOps to Platform Engineering, with Purnima Padmanabhan (https://www.tanzutalk.com/e/purnima-career/) Photo Credits Header (https://unsplash.com/photos/aerial-view-photography-of-the-city-Dymu1WiZVko) Artwork (https://unsplash.com/photos/end-sign-on-beige-sand-TgjSku4-g6Q)

Josh and Kurt talk about some security researchers sort of taking over the .MOBI whois server. The story is a bit sensational, but we ask if it really matters? There are a lot of interesting possible attacks, but turning something like this into a good attack is really hard, maybe impossible. The researchers presented the findings in a very reasonable way. Show Notes We Spent $20 To Achieve RCE And Accidentally Became The Admins Of .MOBI Heinz says sorry for ketchup QR code that links to porn site

This is the third chapter “Three Characteristics” in/from the book: Buddhadhamma: The Laws of Nature and Their Benefits to Lifeby Bhikkhu P. A. Payutto (Somdet Phra Buddhaghosacariya) Published by Buddhadhamma FoundationCopyright © Buddhadhamma Foundation 2021Translated by Robin Philip Moore Editor: Bhikkhu Kovilo, typesetting: Bhikkhu Gambhīro Download this e-book in PDF, EPUB and MOBI formats at the followingContinue reading "“Three Characteristics” Chapter 3 From Buddhadhamma: The Laws Of Nature And Their Benefits To Life"

In this episode of the Stock Day Media Podcast, host interviews Josh Sodiatis, CEO of Peer to Peer Network (Mobi Card). Josh announces two major updates: the company's approval for crowdfunding via a FINRA-registered intermediary, allowing unaccredited investors to invest as little as $250, and a legal opinion ruling Mobi Coin as a utility token. He explains how these updates could positively impact the company's stock and investment opportunities. Josh also elaborates on Mobi Coin's role as a digital business card and the marketing potential of crowdfunding, emphasizing its democratizing effect on investment.

What is the best insulin pump? Today's guest would be the one to know. Gary Scheiner, author of Think Like a Pancreas, has tried 32 different pumps in his 39 years living with type one. Gary and I chatted about the early days of AID systems, his favorite AID system, looping, and several different pumps, including iLet, Medtronic, Mobi, and Tandem. We also peek into what the future might hold for insulin pumps. This episode is a great resource to help you determine which technology will be the best for YOU. Time Stamps:  (02:28) Keeping Up with Technology Advances(04:18) Gary's 39 Years with Diabetes and 32 Different Pumps (06:27) “It's not the tool, it's the user.”(07:40) “Is there a best pump?” and finding the right one(11:00) The Early Days of AID Systems(13:39) His Favorite Aid System (16:05) Looping (18:44) The Gap Between Health Care & Tools Education(21:57) The iLet Pump(25:26) “I don't like people to start on a pump without learning self-management skills.”(27:45) Medtronic (29:08) Mobi (29:58) Tandem (31:33) The Future of Insulin Pumps(35:16) “What does reclaim your rise mean to you?”What to do now:Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop when new episodes drop.Learn more about our 1:1 coaching programs HERE.  Learn more about Temp Monitor HERE Buy Temp Monitor HEREFind Gary on Instagram and his book Think Like a Pancreas on Amazon.Disclaimer: Nothing you hear on the Reclaim your Rise podcast should be a substitute for personalized professional medical advice. Please always consult your physician or other medical professional before making any changes to your diet, insulin dosages, or healthcare plan. 

This is the second chapter “Six Sense Spheres” in/from the book: The Laws of Nature and Their Benefits to Lifeby Bhikkhu P. A. Payutto (Somdet Phra Buddhaghosacariya) Published by Buddhadhamma FoundationCopyright © Buddhadhamma Foundation 2021Translated by Robin Philip Moore Editor: Bhikkhu Kovilo, typesetting: Bhikkhu Gambhīro Download this e-book in PDF, EPUB and MOBI formats at the followingContinue reading "“Six Sense Spheres” Chapter 2 From Buddhadhamma: The Laws Of Nature And Their Benefits To Life"

Drop 1: MOBI Passport MVPhttps://www.ledgerinsights.com/honda-mazda-nissan-complete-1st-phase-of-web3-global-battery-passport-mvp/Drop 2: DAOs in the UKhttps://lawcom.gov.uk/project/decentralised-autonomous-organisations-daos/Drop 3: MakerDAO RWA Competitionhttps://www.coindesk.com/business/2024/07/12/makerdaos-1b-tokenized-treasury-investment-plan-draws-interest-from-blackrocks-buidl-ondo-superstate/ Trexx anuncia microcrédito com ativos de jogos e investe em projetos sociaishttps://br.beincrypto.com/trexx-anuncia-microcredito-com-ativos-de-jogos-e-investe-em-projetos-sociais/New JP Morgan report: Web3: A new era for social commercehttps://www.jpmorgan.com/onyx/content-hub/web3-a-new-era-for-social-commerceAgrotoken Joins Forces with Tanssi to Transform Agro-Finance in Brazil & Argentinahttps://www.tanssi.network/post/collaboration-tanssi-agrotokenCardano Stablecoin USDA To Resume Launch Under New Ownership, Encryptushttps://www.emurgo.io/press-news/cardano-stablecoin-usda-to-resume-launch-under-new-ownership/Zodia Custody to support Maple Finance tokens and serve as custodian to lending collateral for the Maple protocolhttps://maple.finance/news/zodia-custody-enters-strategic-partnership-with-maple-finance . Redes sociais / comms.. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com

Drop 1: MOBI Passport MVPhttps://www.ledgerinsights.com/honda-mazda-nissan-complete-1st-phase-of-web3-global-battery-passport-mvp/Drop 2: DAOs in the UKhttps://lawcom.gov.uk/project/decentralised-autonomous-organisations-daos/Drop 3: MakerDAO RWA Competitionhttps://www.coindesk.com/business/2024/07/12/makerdaos-1b-tokenized-treasury-investment-plan-draws-interest-from-blackrocks-buidl-ondo-superstate/ More: Trexx anuncia microcrédito com ativos de jogos e investe em projetos sociaishttps://br.beincrypto.com/trexx-anuncia-microcredito-com-ativos-de-jogos-e-investe-em-projetos-sociais/New JP Morgan report: Web3: A new era for social commercehttps://www.jpmorgan.com/onyx/content-hub/web3-a-new-era-for-social-commerceAgrotoken Joins Forces with Tanssi to Transform Agro-Finance in Brazil & Argentinahttps://www.tanssi.network/post/collaboration-tanssi-agrotokenCardano Stablecoin USDA To Resume Launch Under New Ownership, Encryptushttps://www.emurgo.io/press-news/cardano-stablecoin-usda-to-resume-launch-under-new-ownership/Zodia Custody to support Maple Finance tokens and serve as custodian to lending collateral for the Maple protocolhttps://maple.finance/news/zodia-custody-enters-strategic-partnership-with-maple-finance . Redes sociais / comms.. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com

In his best-selling book, Sapiens, Yuval Noah Harari describes the most important feature that separates human beings from all other species on the planet: Imagination. We have the ability to imagine something that does not (yet) exist, communicate the concept to others and persuade them to believe it. As a concrete example, he cites the limited liability company, an idea first hatched by the Dutch back in the 1600s. Today we are going to explore the imaginative idea of Web 3.0, an ambitious project to take usout of the quagmire that has become Web 2.0. The basic goal is to create a private internet that is much safer and more efficient than what we have today. Getting there will require imagination, education and a lot of believing. To get us on the path, we are very pleased to have as our guest Tram Vo, co-founder of MOBI, an organization that is building the infrastructure to make Web 3.0 possible. 

I spoke with Lissie Poyner, T1D and Diabetes Health Coach, about her experience on the Tandem Mobi system and why she decided to make the switch from Omni Pod. Lissie and I walk through all of the details and features of the Mobi, how it compares to other systems, and her likes and dislikes overall.   Get Skin Grip patches (10% off w/ JUSTIN10) Thanks to our sponsor, Skin Grip. Code won't combine with other promos.   Fill out T1D Exchange Registry    Join Patreon for Exclusive Content | Join Diabetech Community Discord   Follow Lissie   Follow my other pages: Instagram | Tik Tok | YouTube | Facebook   Send us Feedback & Join the Newsletter   DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. 

In this podcast episode, Andrew interviews Joshua Sodaitis, CEO of Peer to Peer Network, about their product, the Mobi Card. The Mobi Card is a digital business card platform that allows for easy sharing of multimedia content across social networks. Joshua highlights its growth, with an 832% user increase shortly after launch, and discusses future enhancements like enterprise signups. He outlines revenue strategies, including advertising and subscriptions, and teases the reintroduction of the Mobi Coin reward program. Listeners interested in the Mobi Card can find more information or download the app from the company's website or app stores.

Nová gorilí mláďata – chovatelské úspěchy pražské ZOO V noci se narodilo další mládě, jeho matkou je samice Kijivu. Jde o druhý letošní přírůstek. Na začátku ledna se narodila samička, která dostala jméno Mobi. Pražská zoo chová gorily nížinné od roku 1963. Prvním gorilím chovancem zahrady byl samec Titan, po něm do zoo přišla samice Nigra. První mládě narozené v české zoo byla populární samička Moja. V listopadu 2011 odcestovala do Španělska, kde žije v parku Cabárceno. A druhé téma dnešní 90' - podíváme se na důvody, které vedou rodiče k tomu, že tak často žádají o odklad školní docházky. https://www.ceskatelevize.cz/porady/11412378947-90-ct24/224411058130412/

Approved last year, Tandem's Mobi is now widely available. We're getting an update from Ben Mar, Director of Product Marketing, on the features of the Mobi that make this tiny pump different and we look ahead to what Tandem is working on next. Ben also answers your questions about everything from algorithm updates, international access, and much more This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here

In this episode Lissie shares her personal and professional insights on managing diabetes, emphasizing the importance of advocacy and informed decision-making. Highlighting lessons not usually covered by endocrinologists, she dives into her own experiences with type 1 diabetes, Crohn's disease, and the unique challenges faced, including a recent conversation about pre-colonoscopy insulin management. Lissie discusses her decision to switch from the Omnipod to the Tandem Mobi insulin pump, detailing the pros and cons of each system, her experience transitioning pumps, and the impact on her diabetes management. Show Notes: 00:00 Welcome and Introduction 00:25 The Instagram Story That Sparked a Conversation: Preparing for a Colonoscopy with Diabetes 02:42 Navigating Medical Advice and Advocating for Your Health 05:35 Switching Insulin Pumps: From Omnipod to Tandem Mobi 15:40 The Tandem Mobi Experience: Initial Impressions and Data Analysis 21:39 Pros of Tandem Over Omnipod: Size, Modes, and Flexibility 26:48 Cons of Tandem: Tubing Annoyances and Alert Overload 30:11 FAQs: Addressing Common Concerns and Misconceptions 38:28 The Importance of Understanding Your Body Beyond Technology 41:17 Invitation to Join 'Keeping It 100' Resources for this episode: Take our free quiz: http://needlesandspoons.com/quiz-optin Join us inside the Keeping it 100 Diabetes Coaching Experience: https://bit.ly/3E5TX5W Grab the Keeping it 100 Diabetes Journal: https://www.amazon.com/dp/B0BB5ZL6R8?ref_=pe_3052080_397514860 Check out our blog: https://bit.ly/3AkABcm Follow us on Instagram: https://bit.ly/3hMqhU9 Check out our free resource hub: https://bit.ly/3tF2tnC Try Skin Grip and use the code "LISSIE" at try.skingrip.com/podcast⁠ Check out our favorite products: https://www.amazon.com/shop/needlesandspoons_?ref=ac_inf_tb_vh *Disclaimer: Nothing inside of Keeping it 100 Radio or our resources is intended as medical advice. Always consult a physician before making changes to your insulin doses, diet or general wellness.

Evaluating Diabetes Technology: The Pros & Cons of Different Devices – Featuring David Ahn, MD Endocrinologist; Chief of Diabetes Services, HoagTAKING CONTROL OF YOUR DIABETES® - THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusIn this episode, we talk about the most popular CGM and insulin delivery systems that have changed the diabetes world. Our special guest David Ahn, MD, Endocrinologist and chief of Diabetes Services, Hoag shares his insights on diabetes technology and it's future.In this episode, we will talk about:Who is David Ahn?The importance of CGM technology in the modern worldCGMs covered in this episode: Dexcom G7, Libre 2, Libre 2 PLUS and Libre 3, EversenseHybrid closed-loop systems overview & insulin delivery systems (AID): Tandem & Mobi from Control IQ, Omnipod 5, Medtronic 780G, iLet Bionic PancreasHow CGMs influence a basal insulin rateAn “algorithm” as a brain of CGMSteve's experience with Medtronic 780GFollow our guest David Ahn on Instagram: https://www.instagram.com/ahncall/Connect with Our Supporting Diabetes Companies:Dexcom: https://shorturl.at/wzARXMedtronic: https://shorturl.at/orwB8**Tune in for 2 new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** ★ Support this podcast ★

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Tandem announces it's taking orders and starting to ship the Mobi pump, Insulet gets European approval for the Abbott Libre integration with Omnipod 5, new study looks at type 2 remission and gastric bypass surgery, one type of medication seems to do a much better job preventing kidney stones in people with type 2, big new grant to look at exercise and type 1 and a look back at diabetes at the Super Bowl. Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com  

In this episode of the OpsStars podcast, Rachel Squire, Marketing Operations Consultant at MOBI Solutions, joins Don Otvos to share thoughts on the future of marketing and revenue operations. They dive into the impact of AI on the industry, how RevOps is becoming a strategic partner in businesses, and the role of analytics in marketing and revenue operations.

This episode walks through all of the automated insulin pumps currently available in the U.S - the iLet from Beta Bionics, Omnipod, Tandem's tslim X2 and Mobi, and the Medtronic 780g. We cover algorithm and setup, water resistance, cgm support, which is best for who, and how cost and warranties work.   Gary's Practice Gary's Book Think Like a Pancreas   DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.   Fill out T1D Exchange Registry    Follow for more: Instagram | Tik Tok | YouTube | Facebook   Watch Video Podcast on Youtube 

Saime Discordi kaudu soovi, et Algorütm räägiks päris maailma IoT projektidest. Kutsusime siis külla Mobi Lab tegevjuhi Veiko Raime, kes meile rääkis oma kogemustest IoT projektidega. Episoodi veavad Martin Kapp ja Priit Liivak.Algorütmi toetavad Pipedrive, Nortal ja Veriff.

I speak with Liz Gasser, Tandem's EVP and Chief Strategy Officer, about Dexcom G7 support, Mobi's launch and functionality, and Tandem's upcoming tubeless pump called Sigi. Let us know what you're most excited about in the comments!   Today's Sponsors: Download Gluroo: iOS | Android Fill out T1D Exchange Registry    Follow for more: Instagram | Tik Tok | YouTube | Facebook    Watch Video Podcast on Youtube     More on Tandem's Tubeless Pump    DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Novo Nordisk will discontinue Levemir by the end of 2024, Tandem begins limited launch of software updates that will include Dexcom's G7, Beta Bionics iLet pump will be covered until some pharmacy plans, and lots more! Links and transcript below Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX This week was World Diabetes Day so there is a LOT going on.. Our top story is XX Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives. The Danish drugmaker said supply disruptions would start in mid-January, followed by discontinuation of the Levemir injection pen in April and of Levemir vials by the end of 2024. Novo has another long-acting insulin, Tresiba, on the market and says quote - "global manufacturing constraints, significant formulary losses impacting patient access effective in January 2024, and the availability of alternative options in the U.S. market" are key factors in the decision. The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir. Novo, which overtook LVMH (LVMH.PA) as Europe's most valuable listed company this year, posted record operating profit for the third quarter, with sales of its obesity drug Wegovy reaching $1.36 billion, up 28% from the previous quarter. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-discontinue-levemir-insulin-us-market-2023-11-08/ XX Big news from Tandem Diabetes this week – first, their Control IQ algorithm gets FDA approval for children as young as two years old. the technology's original 2019 clearance limited its use to those aged 6 and older. And.. they are officially rolling out the software update that will allow users to connect to either the Dexcom G6 or G7 CGM. If you're in the limited launch you got an email this week telling you the next steps – wider release is expected gradually in the first part of 2024. Integration with Abbot's FreeStyle Libre is expected very soon as well – which would mean Tandem's tslim x2 and Mobi pumps would be compatible with three CGMs. Full disclosure: there wasn't a media release that I received on this, but my son is in the limited launch group so we got the email.   https://www.fiercebiotech.com/medtech/tandem-diabetes-care-cruises-fda-ok-toddler-use-automated-insulin-delivery-algorithm XX Beta Bionics iLet pump and its supplies are now covered as part of some pharmacy benefits - Express Scripts added it to its national formulary list. Historically, insulin pumps fall under the durable medical equipment (DME) insurance benefit. Usually pharmacy benefits are more flexible with fewer up front costs. The system uses an adaptive, closed-loop algorithm that initializes with the user's body weight and requires no additional insulin dosing parameters. The algorithm removes the need to manually adjust insulin pump therapy settings and variables. iLet simplifies mealtime use by replacing conventional carb counting with its meal announcement feature. This enables users to estimate the amount of carbs in their meal, categorized as “small,” “medium” or “large.” Over time, the algorithm learns to respond to users' individual insulin needs. https://www.drugdeliverybusiness.com/beta-bionics-pharmacy-benefit-bionic-pancreas/ XX The UK has launched a pioneering study to explore the development of type 1 diabetes in adults which aims to screen 20,000 individuals. Research will enable earlier and safer diagnosis of type 1 diabetes through blood tests. This makes the UK the first country to implement general population screening for type 1 diabetes in both children and adults. The Type 1 Diabetes Risk in Adults (T1DRA) study, launched on World Diabetes Day, seeks to enroll 20,000 adults aged 18 to 70. Supported by The Leona M. and Harry B. Helmsley Charitable Trust and building on the Diabetes UK-funded Bart's Oxford Family study (BOX), T1DRA aims to unravel the mysteries of adult-onset type 1 diabetes. https://www.diabetes.co.uk/news/2023/nov/groundbreaking-study-to-screen-20000-adults-for-type-1-diabetes.html XX The National Institute for Health and Care Excellence (NICE), England's cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology should be made broadly affordable and accessible to help people with Type 1 diabetes better manage the condition. In this month's final draft guidance (PDF), NICE recommended that hybrid closed-loop technology be offered to all people with Type 1 diabetes who are having trouble controlling the condition using their existing devices.   NICE said that it has already devised a five-year rollout plan with the NHS to bring the technology to people with Type 1 diabetes. Hybrid closed-loop systems will be offered first to children, young people, existing insulin pump users and women who are pregnant or planning to become pregnant, after which they'll be issued to adults who have an average HbA1c reading of at least 7.5%. https://www.fiercebiotech.com/medtech/nice-recommends-hybrid-closed-loop-systems-type-1-diabetes-prompting-praise-medtronic XX     Commercial XX Kyle Banks was diagnosed with type 1 diabetes on November 1, 2015 while performing with the traveling production of Disney's The Lion King.  Performing nightly for sold out audiences across the country was a dream come true, but after experiencing symptoms of the onset of type 1 diabetes, the dream temporarily turned into a nightmare. The symptoms he experienced were  typical for the onset of this chronic illness. but with limited knowledge of type 1 diabetes, he had no idea what was occurring or the drastic life change that would soon follow.  In 2020, he founded Kyler Cares in partnership with Children's Hospital New Orleans and has since connected with families from across the country that are living with this disease.  Kyler Cares seeks to improve health outcomes for people of color living with diabetes and ensuring families can access the resources and technology available for better management is the route the organization is taking to achieve that goal. At Kyler Cares we're working to improve health outcomes for people of color living with diabetes by improving access to diabetes technology, creating connections to education and resources, and fostering community as an added system of support on our journeys. Kyler Bear & Friends' T1 Diaries is an eight-part animated series for kids, dedicated to storytelling about life with Type 1 Diabetes. Our series is more than just an educational tool; it's a reflection of real-life stories and an avenue to strengthen community ties. It's a vehicle for us to inspire young people to begin laying a foundation of knowledge and self-confidence with management of T1D that will resonate throughout their lives until a cure for the disease is discovered.   By supporting this series with a donation, you will be contributing to a project that not only educates and informs but also offers comfort and a sense of belonging to kids navigating life with T1D. ‘Kyler Bear's T1 Diaries' isn't just a series; it's a beacon of hope, a source of information, and a testament to the strength found in our amazing T1D community. Join us in bringing these stories to life XX Married At First Sight UK ends this week, but one bride says viewers haven't seen her whole story.   Fans will find out if Tasha Jay, 25, decides to stay with partner Paul Liba on the Channel 4 show.   But Tasha, who has type 1 diabetes, has spoken out about how footage about her condition didn't make the final cut.   While she's "really sad" that it was left out, Tasha's pleased that people are now realising why she behaved in a certain way on the show at times.     Married at First Sight - or MAFS - is a social experiment where experts match complete strangers who try to live as a couple.   Tasha says her wedding day with Paul on the show was a "really beautiful moment" that included her telling Paul about her diabetes and his reaction.   "I got filmed taking my insulin and checking my blood sugar," she tells BBC Newsbeat.. Tasha was diagnosed at aged two and half and says people have asked why that part of her was hidden in the show.   "And I'm like I didn't hide it," she says.   "For whatever reason they haven't shown it, which really upsets me because diabetes is a part of my story."   Tasha believes that, if people had known about her diabetes, it would have changed their perception of certain moments in the show. https://www.bbc.com/news/newsbeat-67368445

Tandem's tiny Mobi pump is FDA approved and set for a limited roll out in the next few weeks. We've got a deep dive into its features. Mobi is phone controlled, but it has a button that delivers insulin and more.. This week we're talking with Ben Mar, Tandem's Director of Product Marketing. We go through all of those features, answer a bunch of your questions about Mobi and about what else is coming up for Tandem. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Mobi: https://www.tandemdiabetes.com/   Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com    

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new pilot program will allow some pharmacists to prescribe CGMs, Georgia becomes the latest state to pass a law securing Glucagon for schools, new info about COVID-19 and new cases of T1D, insulin pump infusion set and skin reaction study, does kombucha tea lower blood glucose and more! Moms' Night Out early bird specials will end soon for Texas and Rhode Island!  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Find out more about Edgepark Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Transcription: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by AG1. AG1 helps you build your health, foundation first. XX New pilot program to allow pharmacists to prescribe CGMs. This comes from the American Pharmacists Association Foundation, with support from Helmsley Charitable Trust. While many patients with diabetes may not even have access to a primary care physician, the average person interacts with their community pharmacist 12x more often than their primary care provider. The program will launch in 20 community pharmacy practices across the U.S. There will be a 90-day enrollment period followed by 12 months of monitoring and management https://www.businesswire.com/news/home/20230720044367/en/The-APhA-Foundation-launches-patient-enrollment-for-a-program-to-expand-access-to-pharmacist-provided-continuous-glucose-monitoring-CGM-devices-and-services XX We told you recently about Mobi's approval, that's Tandem's tiny pump, billed as the world's smallest durable automated insulin delivery system. Convatec Group now saying they've partnered with Tandem on a new five-inch infusion set for the Mobi. Not a lot more information than that, but interesting because while Convatec makes infusion sets for just about every tubed pump, last year, Tandem acquired another infusion set developer, Capillary Biomedical. https://www.outsourcing-pharma.com/Article/2023/07/18/Convatec-to-manufacture-new-infusion-set-for-Tandem-Diabetes-Care XX New law in Georgia to make sure all schools have emergency glucagon on hand and that it can be used for any student. House Bill 440 took effect on July 1, 2023. It will allow public and private schools in Georgia to acquire and keep a supply of glucagon. It allows prescribers to provide standing orders or prescriptions for ready-to-use glucagon to schools so that this medication can be rapidly administered to students in an emergency. Schools will also be able to work directly with glucagon manufacturers or third-party suppliers to obtain the products for free or at fair market or reduced prices. In 2018 a school nurse in Illinois used another students glucagon on a different study having an emergency, breaking the law. It's since been changed in Indiana and now, in Georgia. Disclaimer: the state rep who sponsored this bill, Doug Stoner is married to my dear friend Trip Stoner who lives with type 1. https://www.thegeorgiavirtue.com/georgia-legislature/georgia-bill-to-help-schools-treat-hypoglycemic-emergencies-becomes-law/ XX I think most of us know this but good to see research on it. A new study shows skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure. researchers at the University of Washington, in Seattle, used biopsies and noninvasive imaging to compare insulin pump sites with control sites in 30 patients. They found Several differences were found at pump sites in comparison with control sites, including fibrosis, inflammation, eosinophils, a disease-fighting white blood cell which indicated an allergic reaction here. The inflammatory response, they say, "may result in tissue changes responsible for the infusion site failures seen frequently in clinical practice." Nearly all patients (93.3%) reported itchiness at the site, and 76.7% reported skin redness. While the researchers think preservatives in the insulin or the makeup of the infusion sets are probably to blame, they admit they don't really understand it fully yet. https://www.medscape.com/viewarticle/995068 XX Very large new study seems to confirm that the COVID-19 pandemic precipitated a jump in cases of type 1 diabetes in children and teenagers. This study pooled data from 17 previous studies and looked at 38-thousand people under the age of 19. They found the incidence of type 1 was about 14-percent higher during 2020, the first year of the pandemic, than in the previous year. The incidence rose higher still in the second year of the pandemic, up 27% from 2019. Before COVID-19, the incidence of type 1 diabetes in children was rising at a steady rate of around 2–4% a year. The meta-analysis did reaffirm that children diagnosed with type 1 diabetes tended to present with more severe forms of disease during the pandemic than before. The incidence of diabetic ketoacidosis, a potentially life-threatening complication of new-onset type 1 diabetes, rose by 26% from 2019 to 2020, probably because people were hesitant or unable to seek emergency care when early symptoms appeared. It's still unclear what triggered the sudden increase in diabetes and how long the trend might persist. It's also important to keep in mind that a few researchers have spoken out that they believe the increase sounds implausible. And that Studies from Finland7, Scotland8 and Denmark9 could not directly link coronavirus infections to the increase in type 1 diabetes. https://www.nature.com/articles/d41586-023-02322-0 XX Commercial – AG1 XX New research shows the best time to predict childhood type 1 diabetes is ages 2-6, when screening detects 80-percent of future cases. Research shows screening children ages 2-6 best predicts childhood type 1 diabetes, successfully detecting 80% of future cases. Early screening also leads to more timely treatment, better health outcomes, and less diabetes distress. These researchers reviewed findings that screened 90-thousand children under the age of 6 and 32-thousand children under 18. These researchers emphasized the need to work towards the adoption of universal screening at the state government, payer, and healthcare provider levels. https://diatribe.org/early-diabetes-screening-kids-can-improve-quality-life XX Very small pilot study suggesting that kombucha reduces blood glucose levels in adults with type 2. I'm including this because you'll likely hear a lot about it.. but keep in mind, the sample size was too small for statistical significance. A total of 12 participants with type 2 diabetes were randomly assigned to consume 240 mL of either a kombucha product or placebo daily with dinner for 4 weeks. They then waited 8 weeks and switched to the other product for another 4 weeks. Kombucha significantly lowered average fasting blood glucose – on average from 164 to 116. Kombucha tea is a fermented drink made with tea, sugar, bacteria and yeast. https://www.medscape.com/viewarticle/995035 XX Afon, a Welsh based company, is working on a non-invasive glucose sensor that has the potential to revolutionize the way blood glucose levels are monitored. We've heard these types of promises before, but are yet to see something materialise into a real-world product. With the development of optical sensors in the early 2010s, the concept of using technology to monitor glucose levels in a non-invasive manner was first brought up. Light is used by these sensors to obtain signals from beneath the skin. For several years, there has been discussion about incorporating such technology for glucose monitoring by smartwatches. Afon adopts an entirely different approach. Its blood glucose sensor is called Glucowear. It is an RF sensor that fits under the base of the wrist. The gizmo uses radio frequencies to obtain signals from beneath the skin. Unlike optical sensors this technology provides real-time monitoring with no time lag. Hoping for a 2024 launch date The company stated that they hope to have the device on the market by early 2024. This is an extremely optimistic goal given the stringent requirements imposed by health regulators. There is no information available on how well Afon is progressing with regulatory approval, and the company's website makes no mention of the regulatory process. So far the Afon Blood Glucose Sensor has undergone three rounds of testing at Profil, a world-renowned diabetes research center in Germany. A multi-phase trial of this technology will be conducted at Swansea University's Joint Clinical Research Facility (JCRF) later in 2023. There will also be other multi-site trials before the device hits retail in 2024. Glucowear delivers real-time continuous glucose monitoring through its wireless integration with a smart device. Designed to be placed under a user's smartwatch, the sensor allows the said device to serve as an integral part of the monitoring system. Afon promotes the Glucowear as a comfortable wearable and ensures that the painless CGM has a battery lifespan of up to 14 days when fully charged. https://gadgetsandwearables.com/2023/07/24/afon-blood-glucose-sensor/ XX https://www.medpagetoday.com/popmedicine/cultureclinic/105707 XX On the podcast next week.. talking to Justin, better known as DiabeTech, who was diagnosed with T1D by TikTok! Last week I talked to the author of Sweeite! That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.  

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new insulin pump gets FDA approval, once-weekly basal insulin for type 2 gets through another trial, New Jersey caps insulin prices for some, possible link between ability to chew and glucose control, a landmark diabetes study moves on to aging and T1D, JDRF Children's Congress and more! Learn about Moms' Night Out - a new event for moms of children with diabetes Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by AG1. AG1 helps you build your health, foundation first. XX Our top story, Tandem's Mobi Pump is approved. The FDA cleared the tiny pump for people with diabetes ages six and up. Tandem says mobie is fully controllable from a mobile app and is the world's smallest durable AID system. It still has a button on the pump to dose and holds 200 units. You use the same infusion set as the current Tandem pumps and Mobi uses Control IQ. Limited release planned for late this year and fully available early 2024. https://www.drugdeliverybusiness.com/fda-clears-tandem-mobi-automated-insulin-pump/ XX Learning more about a newly approved therapy for type 1 diabetes called Lantidra. Two safety and efficacy studies found that 21 participants who took Lantidra did not need to administer themselves insulin for a year or more. Twelve of those participants did not need to take insulin for up to 5 years, and 9 did not need insulin for over 5 years. Lantidra is an allogeneic (donor) pancreatic islet cellular therapy. In other words, Lantidra uses cells taken — or isolated — from human organ donor pancreases. “In [a] subsequent process, the insulin-producing islets are purified from the rest of the pancreatic tissue using a density gradient. Once the islets are isolated, purified, and put for a short time in cell culture, the cell preparation is infused into the liver of the recipient,” he explained. https://www.medicalnewstoday.com/articles/fda-approves-first-cellular-therapy-for-type-1-diabetes-what-does-it-do#How-does-islet-cellular-therapy-work? XX Once weekly basal insulin for type 2 gets through another trial. After 26 weeks of treatment and five weeks of follow-up, patients on weekly insulin icodec had significantly larger improvements in their HbA1C than those using daily insulin. Both groups had an extremely low rate of adverse events. These researches say next step is FDA evaluation. https://www.utsouthwestern.edu/newsroom/articles/year-2023/july-weekly-insulin-found-safe.html XX That's the idea behind Fractyl Health's treatment for type 2 diabetes—which could also be used for weight control. The Lexington, Massachusetts-based biotech company is in the early stages of developing a one-time gene therapy intended to lower blood sugar and body weight using the same mechanism as semaglutide. “You have this problem where you need to stay on therapy for efficacy,” says Harith Rajagopalan, a cardiologist by training and CEO and cofounder of Fractyl Health. “That's the Achilles heel.” The company wants to deliver an artificial gene to the pancreas that continuously produces the GLP-1 hormone so there's no need for weekly injections. The approach, called gene therapy, uses inactivated viruses to carry a therapeutic gene to pancreatic cells. (Viruses are used because of their natural ability to deliver genetic material to cells.) The company is aiming to begin an initial human trial by the end of 2024 https://www.wired.com/story/a-one-time-shot-for-type-2-diabetes-a-biotech-company-is-on-it/ XX Gov. Phil Murphy signed three bills into law Monday aimed at cutting the high cost of prescription drugs in New Jersey. The new laws will cap how much residents will pay for some popular medications such as insulin, prevent pharmacy benefit managers from engaging in practices that make drugs more expensive, and create a panel that will monitor prices set by pharmaceutical companies. One measure (S1614) would cap the cost of insulin, epinephrine auto-injector devices and asthma inhalers for state and local public workers enrolled in the State Health Benefits Program, the School Employees' Health Benefits Program and other state-regulated plans. For a 30-day supply, insulin will cost $35, EpiPens $25 and asthma inhalers would be capped at $50, according to the bill. The law takes effect next year. https://www.nj.com/politics/2023/07/new-laws-to-stem-high-cost-of-prescription-drugs-in-nj-were-just-signed-by-gov-murphy.html XX The European Medicines Agency (EMA) said on Tuesday it has extended its probe into Novo Nordisk's (NOVOb.CO) diabetes drugs Ozempic and weight-loss treatment Saxenda, following two reports of suicidal thoughts, to include other drugs in the same class. The agency began its review on July 3 after Iceland's health regulator flagged the reports of patients thinking about suicide and one case of thoughts of self harm after use of Novo's drugs. https://www.reuters.com/business/healthcare-pharmaceuticals/eu-extends-ozempic-probe-include-other-drugs-2023-07-11/ XX We often hear that diabetes can lead to problems with your teeth.. but one researcher says it might be the other way around. A University at Buffalo researchers says there is a notable correlation between chewing functionality and blood glucose levels in people with type 2. Specifically, he found that patients with T2D who maintain a full chewing ability exhibit significantly lower blood glucose levels compared to those with compromised chewing function. The thinking here is that chewing stimulates the body in all sorts of ways, including releasing hormones that help you feel fuller and help in digestion. More studies are expected. DOI: 10.1371/journal.pone.0284319 https://scitechdaily.com/the-surprising-connection-between-chewing-and-type-2-diabetes/ XX The next step of the landmark Diabetes Control and Complications Trial will focus on aging with type 1 diabetes. The original randomized DCCT clinical trial results, published September 30, 1993, in the New England Journal of Medicine, proved that early intensive glycemic control was the key to preventing or slowing the progression of long-term eye, kidney, and nerve complications of type 1 diabetes. Subsequently, EDIC has yielded many more major findings including that early tight glycemic control also reduces cardiovascular risk and prolongs survival in type 1 diabetes. subsequent EDIC data also have suggested that it is never too late to initiate intensive glycemic control Together, DCCT and EDIC — both funded by the National Institutes of Health at 27 sites in the United States and Canada — have changed the standard of care for people with type 1 diabetes Prior to the DCCT, between 1930 and 1970, about a third of people with type 1 diabetes developed vision loss and one in five experienced kidney failure and/or myocardial infarction. Stroke and amputation were also common, DCCT/EDIC chair David M. Nathan, MD, said while introducing the symposium. "All of the advances in care of type 1 diabetes have developed because this study demonstrated that it was important — continuous glucose monitoring (CGM), new insulins, better [insulin] pumps…I think the most profound finding is that mortality in our intensively treated cohort is the same as in the general population. That says it all," Nathan told Medscape Medical News. https://www.medscape.com/viewarticle/994221 XX Commercial – AG1 XX Today, JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, urged members of the Senate Appropriations Committee to renew the Special Diabetes Program (SDP) and support policies to ensure insulin is available at an affordable and predictable price. Opened by U.S. Senator Patty Murray (D-WA) and led by U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), the hearing took place during the 2023 JDRF Children's Congress, a biennial event that brings over 160 kids and teens living with T1D face-to-face with lawmakers and top decision-makers. The youth delegates traveled to Washington, D.C. from across the country and JDRF's international affiliates in the United Kingdom, Australia, the Netherlands, and Canada. The SDP has accelerated the pace of T1D research through a long-term investment of funding at the National Institutes of Health. The program has led to significant scientific breakthroughs, including Tzield, the first disease-modifying treatment for T1D, which can delay the onset of the disease by over two years. Without Congressional action, the SDP will expire at the end of September. "The Special Diabetes Program has fundamentally changed what it means to live with diabetes, put new life-changing therapies in our hands, and brought us closer to cures," said Aaron Kowalski, Ph.D., JDRF CEO. "We must keep this momentum going so we can capitalize on the progress to date and realize cures. However, until we have cures, people need access to affordable insulin. JDRF urges Congress to pass the bipartisan INSULIN Act of 2023, which will establish a $35 per month insulin copay cap for people with commercial insurance and includes other provisions that would make insulin more affordable for everyone, regardless of insurance status." Dr. Kowalski was joined at the hearing by Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health, who provided testimony on the scientific value of the SDP, and Jimmy Jam, award-winning producer, songwriter, musician, member of the Rock & Roll Hall of Fame, and T1D parent. "My son Max, who is now in his twenties, was just two years old when he was first diagnosed with type 1 diabetes. Late nights working on music became late nights working on music and waking up my son to test and manage his blood sugar levels," said Jimmy Jam. "Type 1 diabetes should be one of those things we can all agree on. Diabetes doesn't care if you're a Democrat or a Republican. We can all agree that there should be research to improve the lives of those with diabetes. We can all agree that insulin should be affordable for all who need it." Two 2023 JDRF Children's Congress delegates shared their T1D experience with the committee: Maria Muayad: 10-year-old Maria is from Maine and is a member of her school's civil rights club and math challenge group. Every November, Maria, and her mother, Golsin, give blue ribbons to the staff at her school in honor of National Diabetes Awareness Month. Elise Cataldo: 15-year-old Elise lives in New Hampshire and is passionate about educating those around her about life with T1D and tries to use things like pump site changes and blood sugar checks as opportunities to help others learn. Following the hearing, the 2023 JDRF Children's Congress delegates continued their advocacy by meeting with lawmakers in their Capitol Hill offices. https://www.prnewswire.com/news-releases/2023-jdrf-childrens-congress-delegates-urge-lawmakers-to-support-type-1-diabetes-research-and-access-to-affordable-insulin-301874927.htmlXX XX A 23-year-old with type 1 diabetes has broken the record for circumnavigating Britain in a kayak after paddling 2,000 miles in 40 days. Dougal Glaisher beat the previous record by 27 days. Glaisher was diagnosed with type 1 diabetes at the age of 19 shortly after winning the Oban Sea Kayak race in Scotland, when he had blurred vision and struggled to recover his energy. The expedition was to raise money for the UK-based charity Action4Diabetes and Glaisher livestreamed his blood sugar On Tuesday he was well stocked with a bunch of bananas and a stash of cereal bars lashed to his boat. But in remote areas it was more challenging. Around the islands off Scotland he ran out of freeze-dried meals and survived on porridge for several days. He also sourced drinking water from streams. . It is the first time anyone has used a surfski – a kayak that you sit on top of – to paddle around the country. XX On the podcast next week.. I sat down with Dexcom's new Chief Commercial officer to talk about their announcements from this week about the type 2 market and other features important to people with type 1. Our last epoisde is all about Kickass Healthy LADA That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.